The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
Abstract
In the last decade the serotonin transporter gene promoter polymorphism (5-HTTLPR) was likely the most studied genetic variant as predictor of antidepressant response. Nevertheless results are not consistent across studies and previous meta-analysis, since various factors seem to modulate its effect on antidepressant response. With the aim of clarifying this issue, we systematically reviewed literature, selecting 33 studies for an exploratory analysis without any a priori hypothesis. Then we analyzed separately 19 studies performed on Caucasians and 11 on Asians. We tested two phenotypes--remission and response rates--and three genotype comparisons--ll versus ls/ss, ss versus ll/ls and ll versus ss - using the Cochrane review manager. Evaluations were performed separately for SSRIs and mixed/other drugs. Possible clinical modulators were investigated. In the exploratory analysis, we found an association between l allele and l/l genotype and remission. When the analysis was split for ethnic group, in Caucasians we found an association between l allele and both response (OR = 1.58, C.I. 1.16-2.16, p = 0.004), and remission (OR = 1.53, C.I. 1.14-2.04, p = 0.004) in the SSRI group. Only a marginal association between l allele and remission (OR = 1.41, C.I. 1.02-1.95, p = 0.04) survived pooling together mixed antidepressant treatments. In Asians, a small effect of 5-HTTLPR on remission for mixed antidepressants was detected (OR = 2.10, C.I. 1.15-3.84, p = 0.02). Gender, age and age at onset modulated the association in Caucasians. Gender, age and depression severity at baseline modulated the association in Asians. In conclusion, in Caucasians 5-HTTLPR may be a predictor of antidepressant response and remission, while in Asians it does not appear to play a major role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pharmacogenetics studies have shown an association between certain polymorphisms in SLC6A4 and the response to antidepressants in patients with mood disorders.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [131]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
(2014) · Medical Entomology and Zoology · Cited by 17,633
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Hu, X.-Z., Lipsky, R., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B., Xu, K., Arnold, P., Richter, M., Kennedy, J., et al. (2006) · American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,215
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 728
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
Nakamura, M., Ueno, S., Sano, A., & Tanabe, H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000698 · Cited by 636
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Pérez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Self-citation
Cited by
Sorted by citations
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Neurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2017) · Brain · doi:10.1093/brain/awx327 · Cited by 211
AB-GEN Collaborative Group, Pérez, V., Salavert, A., Espadaler, J., Tuson, M., Sáiz-Ruiz, J., Sáez-Navarro, C., Bobes, J., Baca‐García, E., Vieta, E., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1412-1 · Cited by 211
Pharmacogenetics in major depression: A comprehensive meta-analysis
Niitsu, T., Fabbri, C., Bentini, F., & Serretti, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.011 · Cited by 196
Self-citationGene × Environment Interactions: From Molecular Mechanisms to Behavior
Halldorsdottir, T., & Binder, E. B. (2016) · Annual Review of Psychology · doi:10.1146/annurev-psych-010416-044053 · Cited by 222
Epigenetic mechanisms of major depression: Targeting neuronal plasticity
Uchida, S., Yamagata, H., Seki, T., & Watanabe, Y. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12621 · Cited by 181
Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response
Domschke, K., Tidow, N., Schwarte, K., Deckert, J., Lesch, K., Arolt, V., Zwanzger, P., & Baune, B. T. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400039x · Cited by 186
Singh, A. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.2.150 · Cited by 146
Commercial pharmacogenetic-based decision-support tools in psychiatry
Bousman, C., & Hopwood, M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00017-1 · Cited by 146
Adipokines as emerging depression biomarkers: A systematic review and meta-analysis
Carvalho, A. F., Rocha, D. Q. C., McIntyre, R. S., Mesquita, L. M., Köhler, C. A., Hyphantis, T. N., Sales, P. M. G., Machado‐Vieira, R., & Berk, M. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.08.002 · Cited by 138
Lueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., Richter, J., Hamm, A., Wittchen, H.-U., & Domschke, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.005 · Cited by 133
Qiu, A., Shen, M., Buß, C., Chong, Y. S., Kwek, K. Y. C., Saw, S., Gluckman, P. D., Wadhwa, P. D., Entringer, S., Styner, M. A., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx065 · Cited by 123
Biomarkers for major depressive disorder
Hacımusalar, Y., & Eşel, E. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2017.19482 · Cited by 123
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
Singh, A., Bousman, C., Ng, C. H., Byron, K., & Berk, M. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.115 · Cited by 110
Treatment-Resistant Depression Revisited: A Glimmer of Hope
Halaris, A. E., Sohl, E., & Whitham, E. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020155 · Cited by 101
Lotrich, F. E., Albusaysi, S., & Ferrell, R. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.263 · Cited by 92
Genetic variants in major depressive disorder: From pathophysiology to therapy
Gonda, X., Petschner, P., Eszlári, N., Baksa, D., Édes, A. E., Antal, P., Juhász, G., & Bagdy, G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.002 · Cited by 91
Response to Lithium in Bipolar Disorder: Clinical and Genetic Findings
RYBAKOWSKI, J. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000277 · Cited by 94
Gobinath, A. R., Choleris, E., & Galea, L. A. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23872 · Cited by 87
Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications
Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0594-9 · Cited by 84
Self-citationPalma‐Gudiel, H., & Fañanás, L. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.011 · Cited by 87
Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research
Fabbri, C., di Girolamo, G., & Serretti, A. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32184 · Cited by 84
Self-citationFabbri, C., Hosák, L., Mößner, R., Giegling, I., Mandelli, L., Bellivier, F., Claes, S. J., Collier, D. A., Corrales, A., DeLisi, L. E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1208843 · Cited by 84
Self-citationIurescia, S., Seripa, D., & Rinaldi, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9409-6 · Cited by 90
Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder
RYBAKOWSKI, J. K. (2013) · CNS Drugs · doi:10.1007/s40263-013-0040-7 · Cited by 83
Neuropsychiatric issues after stroke: Clinical significance and therapeutic implications
Zhang, S., Xu, M. Y., Liu, Z., Feng, J., & Ma, Y. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i6.125 · Cited by 78
Brunoni, A. R., Kemp, A. H., Shiozawa, P., Cordeiro, Q., Valiengo, L. D. C. L., Goulart, A. C., Coprerski, B., Lotufo, P. A., Brunoni, D., Perez, A. B. A., et al. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.009 · Cited by 84
Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?
Labermaier, C., Masana, M., & Müller, M. B. (2013) · Disease Markers · doi:10.1155/2013/984845 · Cited by 80
5-HTTLPR and gender differences in affective disorders: A systematic review
Gressier, F., Calati, R., & Serretti, A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.027 · Cited by 73
Self-citationBiomarkers for Psychiatric Disorders: Where Are We Standing?
Martins‐de‐Souza, D. (2013) · Disease Markers · doi:10.1155/2013/321071 · Cited by 78
Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety Disorders
Helton, S. G., & Lohoff, F. W. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.15 · Cited by 71
Advances in Biomarkers of Major Depressive Disorder
Huang, T., & Lin, C.-C. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2014.11.003 · Cited by 71
Are there meaningful biomarkers of treatment response for depression?
Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 71
The role of genetics and genomics in clinical psychiatry
Hoehe, M. R., & Morris-Rosendahl, D. J. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/mhoehe · Cited by 69
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study
Breitenstein, B., Scheuer, S., Pfister, H., Uhr, M., Lucae, S., Holsboer, F., Ising, M., & Brückl, T. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000436 · Cited by 67
A neurocognitive model for understanding treatment action in depression
Warren, M., Pringle, A., & Harmer, C. J. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0213 · Cited by 75
Lisoway, A. J., Zai, C. C. H., Tiwari, A. K., & Kennedy, J. L. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.071 · Cited by 71
Gressier, F., Porcelli, S., Calati, R., & Serretti, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.035 · Cited by 64
Self-citationResidual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management
Zajecka, J., Kornstein, S. G., & Blier, P. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12059ah1 · Cited by 65
Pharmacogenomic Testing and Personalized Treatment of Depression
Perlis, R. H. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.204446 · Cited by 61
Prognosis and Improved Outcomes in Major Depression: A Review
Kraus, C., Kadriu, B., Lanzenberger, R. R., Zarate, C. A., & Kasper, S. F. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18205 · Cited by 64
Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy
Kulikov, A. V., Gainetdinov, R. R., Ponimaskin, E. G., Kalueff, A. V., Naumenko, V. S., & Popova, N. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1452912 · Cited by 63
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Radosavljević, M., Štrac, D. Š., Jančić, J., & Samardžić, J. (2023) · Genes · doi:10.3390/genes14051095 · Cited by 68
The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives
Fabbri, C., Corponi, F., Souery, D., Kasper, S. F., Montgomery, S., Zohar, J., Rujescu, D., Mendlewicz, J., & Serretti, A. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy024 · Cited by 62
Self-citationBiomarkers in Child and Adolescent Depression
Zwolińska, W., Dmitrzak‐Węglarz, M., & Słopień, A. (2021) · Child Psychiatry & Human Development · doi:10.1007/s10578-021-01246-y · Cited by 65
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms
Reynolds, G. P., McGowan, O. O., & Dalton, C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12312 · Cited by 58
Hess, G. P., Fonseca, E., SCOTT, R., & Fagerness, J. A. (2015) · Genetics Research · doi:10.1017/s0016672315000099 · Cited by 57
Peterson, K., Dieperink, E., Anderson, J., Boundy, E., Ferguson, L., & Helfand, M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4622-9 · Cited by 56
A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey
Oikonomidis, L., Santangelo, A. M., Shiba, Y., Clarke, F. H., Robbins, T. W., & Roberts, A. C. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22446 · Cited by 54
The genetics of selective serotonin reuptake inhibitors
Kroeze, Y., Zhou, H., & Homberg, J. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.015 · Cited by 55
Fabbri, C., Porcelli, S., & Serretti, A. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900202 · Cited by 57
Self-citationUser considerations in assessing pharmacogenomic tests and their clinical support tools
Mukerjee, G., Huston, A., Kabakchiev, B., Piquette‐Miller, M., van Schaik, R. H., & Dorfman, R. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0065-4 · Cited by 58
Poweleit, E. A., Aldrich, S. L., Martin, L. J., Hahn, D., Strawn, J. R., & Ramsey, L. B. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0017 · Cited by 52
Targeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
Farb, D. H., & Ratner, M. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009126 · Cited by 55
Brennan, F. X., Gardner, K. R., Lombard, J., Perlis, R. H., D, M. F. M., Harris, H. W., & Scott, R. (2015) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.14m01717 · Cited by 55
Neuroimaging genomics in psychiatry—a translational approach
Mufford, M. S., Stein, D. J., Dalvie, S., Groenewold, N. A., Thompson, P. M., & Jahanshad, N. (2017) · Genome Medicine · doi:10.1186/s13073-017-0496-z · Cited by 55
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings
Chang, W., Tanoshima, R., Ross, C. J., & Carleton, B. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030920-025745 · Cited by 54
Schiele, M. A., Zwanzger, P., Schwarte, K., Arolt, V., Baune, B. T., & Domschke, K. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa081 · Cited by 51
5HTTLPR Genetic Variant and Major Depressive Disorder: A Review
Fratelli, C. F., Siqueira, J. W. S., Silva, C. M. D. S., Ferreira, E. A., & da Silva, I. C. R. (2020) · Genes · doi:10.3390/genes11111260 · Cited by 49
Seeking an Objective Diagnosis of Depression
Bilello, J. A. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0076 · Cited by 52
Olgiati, P., Serretti, A., Souery, D., Dold, M., Kasper, S. F., Montgomery, S., Zohar, J., & Mendlewicz, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.004 · Cited by 49
Self-citationPharmacogenetics in Psychiatry
Corponi, F., Fabbri, C., & Serretti, A. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.03.003 · Cited by 48
Self-citationIga, J., Watanabe, S., Numata, S., Umehara, H., Nishi, A., Kinoshita, M., Inoshita, M., Shimodera, S., Fujita, H., & Ohmori, T. (2016) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2527 · Cited by 44
Ren, F., Ma, Y., Zhu, X., Guo, R., Wang, J., & He, L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.058 · Cited by 49
Eap, C. B., Gründer, G., Baumann, P., Ansermot, N., Conca, A., Corruble, E., Crettol, S., Dahl, M., de León, J., Greiner, C., et al. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1878427 · Cited by 51
Kelley, M. E., Dunlop, B. W., Nemeroff, C. B., Lori, A., Carrillo‐Roa, T., Binder, E. B., Kutner, M., Aponte‐Rivera, V., Craighead, W. E., & Mayberg, H. S. (2018) · Depression and Anxiety · doi:10.1002/da.22832 · Cited by 48
Antidepressant pharmacogenetics
Singh, A., Bousman, C., Ng, C. H., & Berk, M. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000023 · Cited by 44
Ng, C. H., Sarris, J. J., Singh, A., Bousman, C., Byron, K. A., Peh, L. H., Smith, D. J., Tan, C. H., & Schweitzer, I. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2340 · Cited by 46
A genome-wide association study of antidepressant response in Koreans
Myung, W., Kim, J., Lim, S.-W., Shim, S., Won, H.-H., Kim, S., Kim, S., Lee, M.-S., Chang, H. S., Kim, J. W., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.127 · Cited by 44
Menke, A. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s146110 · Cited by 41
Aifred Health, a Deep Learning Powered Clinical Decision Support System for Mental Health
Benrimoh, D. A., Fratila, R., Israel, S. A., Perlman, K., Mirchi, N., Desai, S., Rosenfeld, A., Knappe, S., Behrmann, J., Rollins, C. P. E., et al. (2018) · The Springer series on challenges in machine learning · doi:10.1007/978-3-319-94042-7_13 · Cited by 41
Lolak, S., Suwannarat, P., & Lipsky, R. H. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00005-x · Cited by 43
McCarthy, M. J., Chen, Y., DeModena, A., Leckband, S. G., Fischer, E. G., Golshan, S., Suppes, T. M., & Kelsoe, J. R. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211015224 · Cited by 39
Voegeli, G., Cléry-Melin, M.-L., Ramoz, N., & Gorwood, P. A. P. M. (2017) · Drugs · doi:10.1007/s40265-017-0819-9 · Cited by 40
Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome
Zhang, C., Wu, Z., Hong, W., Wang, Z., Peng, D., Chen, J., Yuan, C., Yu, S., Xu, L., & Fang, Y. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.010 · Cited by 38
Progress and prospects in pharmacogenetics of antidepressant drugs
Fabbri, C., Crisafulli, C., Calabrò, M., Spina, E., & Serretti, A. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1202237 · Cited by 38
Self-citationBlood-based biomarkers predicting response to antidepressants
Busch, Y., & Menke, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1844-x · Cited by 36
Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction
Wilson, C., Li, S., Hannan, A. J., & Renoir, T. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107998 · Cited by 36
Sbrini, G., Brivio, P., Bosch, K., Homberg, J. R., & Calabrese, F. (2020) · Genes · doi:10.3390/genes11111248 · Cited by 38
Shinozaki, G., Romanowicz, M., Mrazek, D. A., & Kung, S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.028 · Cited by 35
Raab, K., Kirsch, P., & Mier, D. U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.031 · Cited by 35
Yeo, S., Lim, Z.-J. I., Mao, J., & Yau, W. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0558-4 · Cited by 35
Acosta, H., Kantojärvi, K., Hashempour, N., Pelto, J., Scheinin, N. M., Lehtola, S. J., Lewis, J. D., Fonov, V. S., Collins, D. L., Evans, A., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa158 · Cited by 34
Baumeister, D., Lightman, S. L., & Pariante, C. M. (2016) · Psychopathology Review · doi:10.5127/pr.034413 · Cited by 33
Tang, M., He, T., Meng, Q., Broussard, J. I., Yao, L., Diao, Y., Sang, X., Liu, Q., Liao, Y., Li, Y., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400073x · Cited by 38
EMDR Therapy as a Transdiagnostic Psychotherapy
Dominguez, S. K. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192898357.013.18 · Cited by 32
Pharmacogenetic Tests in Psychiatry
de León, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000522 · Cited by 32
Rao, S., Han, X., Shi, M., SIU, C. O., Waye, M. M. Y., Liu, G., & Wing, Y. K. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.035 · Cited by 33
Santangelo, A. M., Ito, M., Shiba, Y., Clarke, H. F., Schut, E. H. S., Cockcroft, G. J., Ferguson‐Smith, A. C., & Roberts, A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.41 · Cited by 32
Rational site-directed pharmacotherapy for major depressive disorder
Blier, P. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000400 · Cited by 29
Stäker, J., Leucht, S., Laika, B., & Steimer, W. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2013.0217 · Cited by 30
Kovács, D., Gonda, X., Petschner, P., Édes, A. E., Eszlári, N., Bagdy, G., & Juhász, G. (2014) · Annals of General Psychiatry · doi:10.1186/1744-859x-13-17 · Cited by 31
Hong, J. S., Kim, S. M., Bae, S., & Han, D. H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00125 · Cited by 30
Ming, Q., Zhang, Y., Yi, J., Wang, X., Zhu, X., & Yao, S. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0639-y · Cited by 30
Sreeja, V., Jose, A., Patel, S., Menon, B., Athira, K. V., & Chakravarty, S. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105672 · Cited by 30
Khdour, H. Y., Abushalbaq, O., Mughrabi, I. T., Imam, A., Gluck, M., Herzallah, M. M., & Moustafa, A. A. (2016) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2016.00020 · Cited by 31
Chronic Systemic Symptoms in Head and Neck Cancer Patients
Murphy, B. A., Wulff-Burchfield, E. M., Ghiam, M. K., Bond, S. M., & Deng, J. F. (2019) · JNCI Monographs · doi:10.1093/jncimonographs/lgz004 · Cited by 28
Manoharan, A., Shewade, D. G., Rajkumar, R. P., & Adithan, C. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2099-9 · Cited by 28
Serotonin transporter genotype and function in relation to antidepressant response in Koreans
Myung, W., Lim, S., Kim, S., Kim, H. R., Chung, J. W., Seo, M. Y., Kim, J., Carroll, B. J., & Kim, D. K. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2813-y · Cited by 27
Metadata
- Authors
- Porcelli, S., Fabbri, C., & Serretti, A.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Serretti, Alessandro
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 22
- Issue
- 4
- Pages
- 239-258
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2035090322
- Cited by
- 331
- References
- 93
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 18 · 2022: 18 · 2021: 24 · 2020: 19 · 2019: 20 · 2018: 31 · 2017: 27 · 2016: 42 · 2015: 33 · 2014: 27 · 2013: 36 · 2012: 13
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- 5-HTTLPR, serotonin transporter gene, promoter polymorphism, antidepressant response, antidepressant remission, genetic predictors of treatment response, selective serotonin reuptake inhibitors, ethnic differences, Caucasians, Asians, age of onset, depression severity, sex differences
- MeSH terms
- Age Factors, Alleles, Antidepressive Agents, Depression, Female, Genotype, Humans, Male, Polymorphism, Genetic, Promoter Regions, Genetic, Remission Induction, Sex Factors, White People, Asian People, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
